Date | Insider | Price | Amount |
---|---|---|---|
5-30-2023 Insider Buy |
John Bencich CEO |
$5.50 CAGR » |
$27,500.00 5,000 shares |
5-23-2019 Insider Buy |
Richard Alistair Stewart Chairman & CEO |
$3.61 CAGR » |
$63,092.75 17,500 shares |
Also See: Institutional Holders of ACHV
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 05/31/2023 | |
End date: | 04/19/2024 | |
Start price/share: | $6.20 | |
End price/share: | $4.51 | |
Dividends collected/share: | $0.00 | |
Total return: | -27.26% | |
Annualized Gain: | -30.71% | |
Starting investment: | $10,000.00 | |
Ending investment: | $7,274.00 | |
Years: | 0.89 |
Achieve Life Science Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Achieve Life Science insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding ACHV
Free ACHV Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the Achieve Life Science Insider Buying occurred are:
Electromed Insider Buying |